U.S. FDA approves Amgen's cheaper copy of arthritis drug Humira
September 23, 2016 at 16:44 PM EDT
WASHINGTON, Sept 23 (Reuters) - The U.S. Food and Drug Administration on Friday approved a cheaper, biosimilar version of AbbVie's top-selling arthritis drug, Humira.
